The role of cystathionine β-synthase in cancer.

Cystathionine β-synthase (CBS) occupies a key position as the initiating and rate-limiting enzyme in the sulfur transfer pathway and plays a vital role in health and disease. CBS is responsible for regulating the metabolism of cysteine, the precursor of glutathione (GSH), an important antioxidant in the body. Additionally, CBS is one of the three enzymes that produce hydrogen sulfide (H 2 S) in mammals through a variety of mechanisms. The dysregulation of CBS expression in cancer cells affects H 2 S production through direct or indirect pathways, thereby influencing cancer growth and metastasis by inducing angiogenesis, facilitating proliferation, migration, and invasion, modulating cellular energy metabolism, promoting cell cycle progression, and inhibiting apoptosis. It is noteworthy that CBS expression exhibits complex changes in different cancer models. In this paper, we focus on the CBS synthesis and metabolism, tissue distribution, potential mechanisms influencing tumor growth, and relevant signaling pathways. We also discuss the impact of pharmacological CBS inhibitors and silencing CBS in preclinical cancer models, supporting their potential as targeted cancer therapies. • CBS is a key enzyme that regulates the production of cysteine, GSH and H 2 S. • CBS plays a key role in the occurrence and development of cancer. • CBS inhibitors show broad therapeutic promise in cancer treatment. [ABSTRACT FROM AUTHOR]